JLE

Hépato-Gastro & Oncologie Digestive

MENU

Tumeurs neuroendocrines duodénales non métastatiques Volume 26, numéro 3, Mars 2019

  • [1] Walter T. Epidémiologie des tumeurs neuroendocrines digestives : la situation en France. Hépato-Gastro et Oncologie Digestive. 2013;20:160-166.
  • [2] O’Connor J.M., Marmissolle F., Bestani C. Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina : Results from the large database of a multidisciplinary group clinical multicenter study. Mol Clin Oncol. 2014;2:673-684. 5
  • [3] Niederle M.B., Hackl M., Kaserer K., Niederle B. Gastroenteropancreatic neuroendocrine tumours : the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification : an analysis based on prospectively collected parameters. Endocr Relat Cancer. 2010;17:909-918. 4
  • [4] Delle Fave G, Kwekkeboom DJ, Van Cutsem E, et al. ; Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 2012 ; 95 (2) : 74-87.
  • [5] Hallet J., Law C.H., Cukier M., Saskin R., Liu N., Singh S. Exploring the rising incidence of neuroendocrine tumors : a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015;121:589-597. 4
  • [6] Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008 ; 26 (18) : 3063-72.
  • [7] Fitzgerald TL, Dennis SO, Kachare SD, Vohra NA, Zervos EE. Increasing incidence of duodenal neuroendocrine tumors : Incidental discovery of indolent disease? Surgery 2015 ; 158 (2) : 466-71.
  • [8] Dogeas E., Cameron J.L., Wolfgang C.L. Duodenal and Ampullary Carcinoid Tumors : Size Predicts Necessity for Lymphadenectomy. J Gastrointest Surg. 2017;21:1262-1269. 8
  • [9] Vanoli A, La Rosa S, Klersy C, et al. Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum : Analysis of 203 Cases. Neuroendocrinology 2017 ; 104 (2) : 112-125.
  • [10] Randle R.W., Ahmed S., Newman N.A., Clark C.J. Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater : a population-based study. J Gastrointest Surg. 2014;18:354-362. 2
  • [11] Hoffmann K.M., Furukawa M., Jensen R.T. Duodenal neuroendocrine tumors : Classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol. 2005;19:675-697. 5
  • [12] Cadiot G, et al. Tumeurs neuro-endocrines. 2017, Thésaurus National de Cancérologie Digestive. www.tncd.org.
  • [13] Jensen RT, Rindi G, Arnold R, et al. ; Frascati Consensus Conference ; European Neuroendocrine Tumor Society. Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology 2006 ; 84 (3) : 165-72.
  • [14] Massironi S., Campana D., Partelli S. Heterogeneity of Duodenal Neuroendocrine Tumors : An Italian Multi-center Experience. Ann Surg Oncol. 2018;25:3200-3206. 11
  • [15] Kim G.H., Kim J.I., Jeon S.W. Endoscopic resection for duodenal carcinoid tumors : a multicenter, retrospective study. J Gastroenterol Hepatol. 2014;29:318-324. Korean College of Helicobacter, Upper Gastrointestinal Research2
  • [16] Gincul R., Ponchon T., Napoleon B. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors. Endoscopy. 2016;48:979-986. 11
  • [17] Delle Fave G, O’Toole D, Sundin A, et al. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. Neuroendocrinology 2016 ; 103 (2) : 119-24.
  • [18] Lloyd R. WHO Classification of Tumours of Endocrine Organs. 2018.
  • [19] Walter T. No histology for diminutive duodenal neuroendocrine tumors : is it safe? Endoscopy International Open 2018 ; 06 : E1-E2.(sous presse).
  • [20] Min B.H., Kim E.R., Lee J.H. Management strategy for small duodenal carcinoid tumors : does conservative management with close follow-up represent an alternative to endoscopic treatment? Digestion. 2013;87:247-253. 4
  • [21] Khara H. Endoscopic banding without resection (BWR) technique for treatment of diminutive neuroendocrine tumors in the duodenum. Endoscopy International Open 2018. 00.(sous presse).
  • [22] Matsumoto S., Miyatani H., Yoshida Y., Nokubi M. Duodenal carcinoid tumors : 5 cases treated by endoscopic submucosal dissection. Gastrointest Endosc. 2011;74:1152-1156. 5
  • [23] Farges O., Bendersky N., Truant S., Delpero J.R., Pruvot F.R., Sauvanet A. The Theory and Practice of Pancreatic Surgery in France. Ann Surg. 2017;266:797-804. 5
  • [24] Soga J. Endocrinocarcinomas (carcinoids and their variants) of the duodenum. An evaluation of 927 cases. J Exp Clin Cancer Res. 2003;22:349-363. 3